Document:

Exhibit
      10.24

    

    NEITHER
      THIS SECURITY NOR THE SECURITY INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
      BEEN
      REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
      COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
      THE SECURITIES ACT OF 1933, AS AMENDED, AND, ACCORDINGLY, MAY NOT BE OFFERED
      OR
      SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
      ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
      TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
      TO
      THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
      ACCEPTABLE TO THE COMPANY.

    

    Warrant
      No. W-August 07-______

    

    Void
      after 5:00 p.m., Eastern Standard Time on August __, 2012

    

    UNIT
      PURCHASE WARRANT

     

    1. DRTATTOFF,
      LLC, a California limited liability company (the “Company”),
      hereby certifies that, for value received,
      ______________________,
      located at __________________  (the
      “Warrant
      Holder”)
      is the
      owner of the number of unit purchase warrants (“Warrants”)
      which
      entitles the holder thereof to purchase, at any time during the period
      commencing on the Commencement Date (as defined herein) and ending on the
      Expiration Date (as defined herein), ____________ (_____) fully paid and
      non-assessable units of Membership Interest (as defined in the Company's
      Operating Agreement dated as of July 5, 2005, as amended to date (the "Operating
      Agreement")) in the Company (each a "Unit"), at a purchase price equal to the
      Exercise Price (as defined below) in lawful money of the United States of
      America in cash, subject to adjustment as hereinafter provided. Each Unit shall
      include the right to receive allocations of Net Profits and Net Losses and
      distributions from the Company. 

     

    2. WARRANT;
      EXERCISE PRICE.

     

    2.1 This
      Warrant is issued pursuant to a Subscription Agreement dated as of the date
      hereof, by and among the Company and the Warrant Holder (the “Subscription
      Agreement”).

     

    2.2 Each
      Warrant shall entitle the Warrant Holder to purchase one Unit (individually,
      a
“Warrant
      Unit”
      severally, the “Warrant
      Units”).
      Each
      Warrant Unit shall provide the holder of such Unit with a capital account
      balance equal to the exercise price paid for such Warrant Unit. 

     

    2.3 The
      purchase price payable upon exercise of each Warrant (the “Exercise
      Price”)
      shall
      be (i) in the event that the Company completes a merger of the Company with
      and
      into Lifesciences Opportunities, Inc. (the "Merger"), $1.25 per Unit, or (ii)
      if
      the Warrant is exercised prior to the Merger or in the event the Merger does
      not
      occur, then the exercise price shall be $92.72 per Unit, subject to any
      adjustments pursuant to Section 8. Notwithstanding the foregoing, the Exercise
      Price and number of Warrant Units purchasable pursuant to each Warrant are
      subject to adjustment as provided in Section 8. 

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    3. EXERCISE
      OF WARRANT; EXPIRATION DATE. 

     

    3.1 This
      Warrant is exercisable at any time and from time to time commencing the date
      hereof (“Commencement
      Date”)
      and
      ending at 5:00 p.m., Eastern Time on August 1, 2012 (the “Expiration
      Date”),
      in
      whole or from time to time in part, at the option of the Warrant Holder, upon
      surrender of this Warrant to the Company together with a duly completed Notice
      of Exercise in the form attached hereto and payment of an amount equal to the
      then applicable Exercise Price multiplied by the number of Warrant Units then
      being purchased upon such exercise. 

     

    3.2 Each
      exercise of this Warrant shall be deemed to have been effected immediately
      prior
      to the close of business on the day on which this Warrant shall have been
      surrendered to the Company as provided in Section 2.1. At such time, the person
      or persons in whose name or names any certificates for Warrant Units shall
      be
      issuable upon such exercise as provided in Section 2.3 below shall be deemed
      to
      have become the holder or holders of record of the Warrant Units represented
      by
      such certificates.

     

    3.3 Within
      three business days after the exercise of the purchase right represented by
      this
      Warrant, the Company at its expense will use its reasonable best efforts to
      cause to be issued in the name of, and delivered to, the Warrant Holder, or,
      subject to the terms and conditions hereof, to such other individual or entity
      as such Warrant Holder (upon payment by such Warrant Holder of any applicable
      transfer taxes) may direct: 

     

    (a) a
      certificate or certificates for the number of full Warrant Units to which such
      Warrant Holder shall be entitled upon such exercise , and 

     

    (b) in
      case
      such exercise is in part only, a new Warrant or Warrants (dated the date hereof)
      of like tenor, stating on the face or faces thereof the number of Units
      currently stated on the face of this Warrant minus the number of such Units
      purchased by the Warrant Holder upon such exercise as provided in Section 2.2
      (in each case prior to any adjustments made thereto pursuant to the provisions
      of this Warrant).

     

    4. REGISTRATION
      AND TRANSFER ON COMPANY BOOKS. 

     

    4.1 The
      Company (or an agent of the Company) will maintain a register containing the
      names and addresses of the Warrant Holders. Any Warrant Holder may change its,
      his or her address as shown on the warrant register by written notice to the
      Company requesting such change. 

     

    4.2 The
      Company shall register upon its books any transfer of a Warrant upon surrender
      of same as provided in Section 5. 

     

    5. RESERVATION
      OF UNITS.
      The
      Company will at all times reserve and keep available, solely for issuance and
      delivery upon the exercise of this Warrant, such Warrant Units and other stock,
      securities and property, as from time to time shall be issuable upon the
      exercise of this Warrant. As
      long
      as the Warrant shall be outstanding, the Company shall use its commercially
      reasonable efforts to cause all Warrant Units issuable upon exercise of the
      Warrants to be listed (subject to official notice of issuance) on each Exchange
      (or, if applicable on Nasdaq, NASD OTC Bulletin Board or Pink Sheets, LLC or
      any
      successor electronic quotation service and trading market) on which the
      Company's Membership Interests are then listed and/or quoted, if
      any. 

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    6. EXCHANGE,
      TRANSFER, ASSIGNMENT OR LOSS OR MUTILATION OF WARRANTS.
      This
      Warrant is exchangeable, without expense, at the option of the Warrant Holder,
      upon presentation and surrender hereof to the Company for other warrants of
      different denominations entitling the holder thereof to purchase in the
      aggregate the same number of Units purchasable hereunder. Subject to the terms
      of Sections 6 and 7, upon surrender of this Warrant to the Company at its
      principal office or at the office of its transfer agent, if any, with the
      Assignment Form annexed hereto duly executed and funds sufficient to pay any
      transfer tax, the Company shall, without charge, execute and deliver a new
      Warrant in the name of the assignee named in such instrument of assignment
      and
      this Warrant shall be promptly canceled. Subject to the terms of Sections 6
      and
      7, this Warrant may be divided or combined with other warrants which carry
      the
      same rights upon presentation hereof at the principal office of the Company
      together with a written notice specifying the names and denominations in which
      new Warrants are to be issued and signed by the Warrant Holder hereof. The
      term
“Warrant” as used herein includes any Warrants into which this Warrant may be
      divided or exchanged. Upon receipt by the Company of reasonable evidence of
      the
      ownership of and the loss, theft, destruction or mutilation of this Warrant
      and,
      in the case of loss, theft or destruction, of indemnity reasonably satisfactory
      to the Company, or, in the case of mutilation, upon surrender and cancellation
      of the mutilated Warrant, the Company shall execute and deliver in lieu thereof
      a new Warrant of like tenor and date representing an equal number of Warrants.
      

     

    7. LIMITATION
      ON EXERCISE AND SALES. 

     

    8. (a)
       Each
      holder of this Warrant acknowledges that this Warrant and the Warrant Units
      have
      not been registered under the Securities Act, as of the date of issuance hereof.
      This Warrant only may be transferred in compliance with this Section 6 and
      Section 7. The Company shall be under no obligation to issue the Units covered
      by such exercise unless and until the Warrant Holder shall have executed the
      form of exercise annexed hereto that states that at the time of such exercise
      that it is then an “accredited investor” within the meaning of Rule 501 of
      Regulation D, is acquiring such Units for its own account, and will not transfer
      the Warrant Units unless pursuant to an effective and current registration
      statement under the Securities Act or an exemption from the registration
      requirements of the Securities Act and any other applicable restrictions, in
      which event the Warrant Holder shall be bound by the provisions of a legend
      or
      legends to such effect that shall be endorsed upon the certificate(s)
      representing the Warrant Units issued pursuant to such exercise. In such event,
      the Warrant Units issued upon exercise hereof shall be imprinted with a legend
      in substantially the form provided in Section 7(b). 

    

    (b) Warrant
      Holder represents and warrants that it is acquiring this Warrant for its own
      account, for purposes of investment, and not with a view to, or for sale in
      connection with, any distribution thereof within the meaning of the Securities
      Act and the rules and regulations promulgated thereunder. Warrant Holder
      represents, warrants and agrees that it will not sell, exercise, transfer or
      otherwise dispose of this Warrant (or any interest therein) or any of the Units
      purchasable upon exercise hereof, except pursuant to (i) an effective
      registration statement under the Securities Act and applicable state securities
      laws or (ii) an opinion of counsel, satisfactory to Company, that an exemption
      from registration under the Securities Act and such laws is available. Warrant
      Holder further acknowledges and agrees that Company is not required, legally
      or
      contractually, so to register or qualify the Warrant or such Units or to take
      any action to make such an exemption available. Warrant Holder understands
      that
      Company will be relying upon the truth and accuracy of the representations
      and
      warranties contained in this Section 6 in issuing this Warrant and such Units
      without first registering the issuance thereof under the Securities Act or
      qualifying or registering the issuance thereof under any state securities laws
      that may be applicable.

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    (c) Warrant
      Holder acknowledges that (i) there is not now, and there may not be in the
      future, any public market for the Warrant, (ii) although there currently is
      not
      a public trading market for the Units, there can be no assurance that any such
      market will be created and sustained, and (iii) there can be no assurance that
      Warrant Holder will be able to liquidate its investment in Company. Warrant
      Holder represents and warrants that it is familiar with and understands the
      terms and conditions of Rule 144 promulgated under the Securities
      Act.

    

    (d)
       Warrant
      Holder represents and warrants to Company that (i) it has such knowledge and
      experience in financial and business matters as is necessary to enable it to
      evaluate the merits and risks of any investments in Company and is not utilizing
      any other person to be a purchaser representative in connection with evaluation
      of such merits and risks; and (ii) it has no need for liquidity in an investment
      in Company and is able to bear the risk of that investment for an indefinite
      period and to afford a complete loss thereof.

    

    (e) Warrant
      Holder represents and warrants that it has had access to, and has been furnished
      with, all of the information it has requested from Company and has had an
      opportunity to review the books and records of Company and to discuss with
      management and members of the board of directors of Company the business and
      financial affairs of Company.

    

    (f)
       Warrant
      Holder agrees that at the time of each exercise of this Warrant, unless the
      issuance of Units issuable thereupon is pursuant to an effective registration
      statement under the Securities Act and under applicable state blue sky laws,
      Warrant Holder will provide Company with a letter embodying the representations
      and warranties set forth in subsections (b) through (e), in form and substance
      reasonably satisfactory to Company, and agrees that the certificate(s)
      representing any shares issued to it upon any exercise of this Warrant may
      bear
      such restrictive legend as Company may deem necessary to reflect the restricted
      status of such shares under the Securities Act unless Company shall have
      received from Warrant Holder an opinion of counsel to Warrant Holder, reasonably
      satisfactory in form and substance to Company and its counsel, that such
      restrictive legend is not required.

     

    9. TRANSFER
      RESTRICTIONS.

    

    (a) If,
      at the
time
      of
      the surrender of this Warrant in connection with any transfer of this Warrant,
      the transfer of this Warrant shall not be registered pursuant to an effective
      registration
      statement under the Securities Act
      and
under
      applicable state securities or blue sky laws, the Company may require, as a
      condition of allowing such transfer (i) that the Warrant Holder or transferee
      of
      this Warrant, as the case may be, furnish to the Company a written opinion
      of
      counsel (which opinion shall be in form, substance and scope customary for
      opinions of counsel in comparable transactions and reasonably satisfactory
      to
      counsel for the Company) to the effect that such transfer may be made
      without
      registration under the
      Securities Act and under applicable state securities or blue sky laws, (ii)
      that
      the holder or transferee execute and deliver to the Company an investment letter
      in form and substance acceptable to the Company, (iii) that transferee agree
      in
      writing with the Company to be bound by the terms and conditions of this Warrant
      applicable to the Warrant Holder and (iv) that the transferee be an “accredited
      investor” as defined in Regulation D promulgated under the Securities
      Act.

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    (b) The
      Units
      issuable on the exercise of the Warrant shall bear the following
      legend:

     

    THESE
      SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION,
      OR THE SECURITIES COMMISSION OF ANY STATE, IN RELIANCE UPON AN EXEMPTION FROM
      REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
      ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
      EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
      AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
      REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
      SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
      TO
      SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
      COMPANY.

     

    (c) The
      Holder acknowledges that the Warrant Units acquired upon the exercise of this
      Warrant, if not registered, will have restrictions upon resale imposed by state
      and federal securities laws.

     

    10. ADJUSTMENT
      OF EXERCISE PRICE AND NUMBER OF UNITS DELIVERABLE.
      The
      Exercise Price and the number of Warrant Units purchasable pursuant to each
      Warrant shall be subject to adjustment from time to time as hereinafter set
      forth in this Section 8: 

     

    (a) In
      case,
      prior to the expiration of this Warrant by exercise or by its terms, the Company
      shall issue any additional units of Membership Interest as a dividend or
      subdivide the number of outstanding Units into a greater number of units of
      Membership Interest, then in either of such cases, the then applicable Exercise
      Price per Warrant Unit purchasable pursuant to this Warrant in effect at the
      time of such action shall be proportionately reduced and the number of Warrant
      Units at that time purchasable pursuant to this Warrant shall be proportionately
      increased; and conversely, in the event the Company shall reduce the number
      of
      outstanding units of Membership Interest by combining such units into a smaller
      number of units of Membership Interest then, in such case, the then applicable
      Exercise Price per Warrant Unit purchasable pursuant to this Warrant in effect
      at the time of such action shall be proportionately increased and the number
      of
      Warrant Units at that time purchasable pursuant to this Warrant shall be
      proportionately decreased. If the Company shall, at any time during the life
      of
      this Warrant, declare a dividend payable in cash on its Membership Interest
      and
      shall at substantially the same time offer to its stockholders a right to
      purchase new units of Membership Interest from the proceeds of such dividend
      or
      for an amount substantially equal to the dividend, all units of Membership
      Interest so issued shall, for the purpose of this Warrant, be deemed to have
      been issued as a dividend. Any dividend paid or distributed upon the Membership
      Interests in units of any other class of securities convertible into units
      of
      Membership Interest shall be treated as a dividend paid in units of Membership
      Interest to the extent that units of Membership Interest are issuable upon
      conversion thereof.

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    (b) In
      case,
      prior to the expiration of this Warrant by exercise or by its terms, the Company
      shall be recapitalized by reclassifying its outstanding units of Membership
      Interest, (or the Company or a successor corporation shall consolidate or merge
      with or convey all or substantially all of its or of any successor corporation’s
      property and assets to any other corporation or corporations (any such other
      corporations being included within the meaning of the term “successor
      corporation” hereinbefore used in the event of any consolidation or merger of
      any such other corporation with, or the sale of all or substantially all of
      the
      property of any such other corporation to, another corporation or corporations),
      then, as a condition of such recapitalization, consolidation, merger or
      conveyance, lawful and adequate provision shall be made whereby the holder
      of
      this Warrant shall thereafter have the right to purchase, upon the basis and
      on
      the terms and conditions specified in this Warrant, in lieu of the Warrant
      Units
      theretofore purchasable upon the exercise of this Warrant, such shares of stock,
      securities or assets, as may be issued or payable with respect to, or in
      exchange for, the number of Warrant Units theretofore purchasable upon the
      exercise of this Warrant had such recapitalization, consolidation, merger,
      or
      conveyance not taken place, and the exercise price for which shall have been
      appropriately adjusted to reflect the number of securities which the Warrant
      Holder is entitled to purchase in exchange for such Warrant; and in any such
      event, the rights of the Warrant Holder to any adjustment in the number of
      Warrant Units purchasable upon the exercise of this Warrant, as herein provided,
      shall continue and be preserved in respect of any stock which the Warrant Holder
      becomes entitled to purchase.

     

    (c) In
      case
      the Company at any time while this Warrant shall remain unexpired and
      unexercised shall sell all or substantially all of its property or dissolve,
      liquidate, or wind up its affairs, lawful provision shall be made as part of
      the
      terms of any such sale, dissolution, liquidation or winding up, so that the
      holder of this Warrant may thereafter receive upon exercise hereof in lieu
      of
      each Warrant Unit that it would have been entitled to receive, the same kind
      and
      amount of any securities or assets as may be issuable, distributable or payable
      upon any such sale, dissolution, liquidation or winding up with respect to
      each
      Unit of the Company, provided, however, that in any case of any such sale or
      of
      dissolution, liquidation or winding up, the right to exercise this Warrant
      shall
      terminate on a date fixed by the Company; such date so fixed to be not earlier
      than 5:00 p.m., Eastern Time, on the forty-fifth day next succeeding the date
      on
      which notice of such termination of the right to exercise this Warrant has
      been
      given by mail to the registered holder of this Warrant at its address as it
      appears on the books of the Company.

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    11. VOLUNTARY
      ADJUSTMENT BY THE COMPANY.
      The
      Company may, at its option, at any time during the term of the Warrants, reduce
      the then current Exercise Price to any amount deemed appropriate by the Managing
      Members of the Company and/or extend the date of the expiration of the Warrants.
      

     

    12. RIGHTS
      OF THE HOLDER.
      The
      Warrant Holder shall not, by virtue hereof, be entitled to any rights of a
      member in the Company, either at law or equity, and the rights of the Warrant
      Holder are limited to those expressed in this Warrant and are not enforceable
      against the Company except to the extent set forth herein. This Warrant does
      not
      entitle the Holder to any voting rights or other rights as a member of the
      Company prior to the Exercise Date and then only with respect to the Warrant
      Units to be issued with respect thereto. 

     

    13. NOTICES
      OF RECORD DATE. In case: 

     

    (a) the
      Company shall take a record of the holders of its Units (or other stock or
      securities at the time deliverable upon the exercise of this Warrant) for the
      purpose of entitling or enabling them to receive any dividend or other
      distribution, or to receive any right to subscribe for or purchase any
      Membership Interests or any other securities, or to receive any other right,
      or

     

    (b) of
      any
      capital reorganization of the Company, any reclassification of the equity
      capital of the Company, any consolidation or merger of the Company with or
      into
      a corporation or other entity (other than a consolidation or merger in which
      the
      Company is the surviving entity), or any transfer of all or substantially all
      of
      the assets of the Company, or 

     

    (c) of
      the
      voluntary or involuntary dissolution, liquidation or winding-up of the Company,
      

     

    (d) then,
      and
      in each such case, the Company will mail or cause to be mailed to the Warrant
      Holder a notice specifying, as the case may be, (i) the date on which a record
      is to be taken for the purpose of such dividend, distribution or right, and
      stating the amount and character of such dividend, distribution or right, or
      (ii) the effective date on which such reorganization, reclassification,
      consolidation, merger, transfer, dissolution, liquidation or winding-up is
      to
      take place, and the time, if any is to be fixed, as of which the holders of
      record of Units (or such other stock or securities at the time deliverable
      upon
      the exercise of this Warrant) shall be entitled to exchange their Units (or
      such
      other stock or securities) for securities or other property deliverable upon
      such reorganization, reclassification, consolidation, merger, transfer,
      dissolution, liquidation or winding-up. Such notice shall be mailed at least
      ten
      days prior to the record date or effective date for the event specified in
      such
      notice, provided that the failure to mail such notice shall not affect the
      legality or validity of any such action. 

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    14. SUCCESSORS.
      The
      rights and obligations of the parties to this Warrant will inure to the benefit
      of and be binding upon the parties hereto and their respective heirs,
      successors, assigns, pledgees, transferees and purchasers. 

     

    15. CHANGE
      OR WAIVER.
      Any
      term of this Warrant may be changed or waived only by an instrument in writing
      signed by the party against whom enforcement of the change or waiver is sought.
      

     

    16. HEADINGS.
      The
      headings in this Warrant are for purposes of reference only and shall not limit
      or otherwise affect the meaning of any provision of this Warrant. Wherever
      possible, each provision of this Warrant shall be interpreted in such manner
      as
      to be effective and valid under applicable law, but if any provision of this
      Warrant shall be prohibited by or invalid under applicable law, such provision
      shall be ineffective to the extent of such prohibition or invalidity, without
      invalidating the remainder of such provisions or the remaining provisions of
      this Warrant.

     

    17. GOVERNING
      LAW.
      This
      Warrant shall be governed by and construed in accordance with the laws of the
      State of California. Any action or litigation brought by either party against
      the other concerning the transactions contemplated by this Warrant shall be
      brought only in the state courts or in the federal courts located in the state
      of California prevailing party shall be entitled to recover from the other
      party
      its reasonable attorney’s fees and costs.

     

    18. MAILING
      OF NOTICES, ETC.
      All
      notices and other communications required or permitted hereunder shall be in
      writing and shall be deemed to have been duly given one (1) business day after
      delivery to an overnight carrier with instructions to deliver to the applicable
      address set forth below, or, if sent by facsimile, upon receipt of a
      confirmation of delivery: 

     

    19. Registered
      Holder: To
      his or
      her last known address as indicated on the Company’s books and
      records.

     

    20. The
      Company: DrTattoff,
      LLC

     

    
      	
              8500
                Wilshire Blvd,

            
	
              Beverly
                Hills CA 90211

            
	
              Attention:
                James Morel, President

            
	
              Fax:
                310-659-4159

            

    

    

    [Signature
      Page Follows]

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    21. IN
      WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly
      authorized officer as of August __, 2007

     

    22. 

     

    23. DRTATTOFF,
      LLC

     

    24. By: ______________________________

     

    25. Name:
      

     

    26. Title:
      

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    Notice
      of
      Exercise

     

    27. To
      Be
      Executed by the Warrant Holder

     

    28. In
      Order
      to Exercise Warrants

    

    TO:
      Dr.
      Tattoff, LLC

    

    The
      undersigned hereby: (1) irrevocably subscribes for and offers to purchase
      _______ Units (“Units”),
      of
      DrTattoff, LLC, pursuant to Warrant No. ___ heretofore issued to
      ___________________ on August 1, 2007 and (2) encloses a cash payment of
      $__________ representing the aggregate exercise price for such Unitss.

    

    The
      undersigned hereby represents and warrants to the Company that it is an
“Accredited Investor” within the meaning of Rule 501 of Regulation D promulgated
      under the Securities Act of 1933, as amended (the “Securities
      Act”),
      and
      is acquiring these securities for its own account and not with a view to, or
      for
      sale in connection with, any distribution thereof, nor with any present
      intention of distributing or selling the same. The undersigned further
      represents that it does not have any contract, agreement, understanding or
      arrangement with any person to sell, transfer or grant the Units issuable under
      this Warrant. The undersigned understands that the shares it will be receiving
      are “restricted securities” under Federal securities laws inasmuch as they are
      being acquired from DrTattoff, LLC, in transactions not including any public
      offering and that under such laws, such shares may only be sold pursuant to
      an
      effective and current registration statement under the Securities Act or an
      exemption from the registration requirements of the Securities Act and any
      other
      applicable restrictions, in which event a legend or legends will be placed
      upon
      the certificate(s) representing the Units issuable under this Warrant denoting
      such restrictions. The undersigned understands and acknowledges that the Company
      will rely on the accuracy of these representations and warranties in issuing
      the
      securities underlying the Warrant.

    

    [warrant
      notice of exercise signature page to follow]

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

        
        

      

    

     

    Exhibit
      10.24

    [warrant
      notice of exercise signature page]

    

    
      	
              Date:

            	 
	 	 
	
              Warrant
                Holder Name:

            	 
	 	 
	
              Taxpayer
                Identification Number:

            	 
	 	 
	
              By:
                

            	 
	 	 
	
              Printed
                Name:

            	 
	 	 
	
              Title:

            	 
	 	 
	
              Address:

            	 

    

     

    Note:
      The
      above signature should correspond exactly with the name on the face of this
      Warrant or with the name of assignee appearing in assignment form below.

    

    AND,
      if
      said number of shares shall be less than the total number of shares purchasable
      under the Warrant, a new Warrant is to be issued in the name of said undersigned
      for the balance remaining of the shares purchasable thereunder less any fraction
      of a share paid in cash and delivered to the address stated
      above.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    29. ASSIGNMENT
      FORM

     

    30. To
      be
      executed by the Warrant Holder

     

    31. In
      order
      to Assign Warrants

     

    32. 

     

    33. FOR
      VALUE
      RECEIVED,____________________________________ hereby sell, assigns and transfer
      unto

     

    34. PLEASE
      INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER

    

    
      	
               

            

    

     

    35. 

     

      
        

      

       

    

    
      

    

     

    
      

    

    (Please
      print or type name and address)

     

    36. ______________________
      of the Warrants represented by this Warrant, and hereby irrevocably constitutes
      and appoints ________________________ Attorney to transfer this Warrant on
      the
      books of the Company, with full power of substitution in the
      premises.

     

    37. Dated:______________________
        

     

    38.  (Signature
      of Registered Holder)

     

    39.  

     

    40.  

    

    In
      addition to executing this Assignment Form, the Warrant Holder and the
      transferee must comply with the other requirements for transfer set forth in
      Sections 6 and 7 of the Warrant.

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

     

    41. CERTIFICATION
      OF STATUS OF TRANSFEREE

     

    42. TO
      BE
      EXECUTED BY THE TRANSFEREE OF THIS WARRANT

     

    43. 

     

    44. The
      undersigned transferee hereby certifies to the registered holder of this Warrant
      and to DR. TATTOFF, LLC that the transferee is an “accredited investor” within
      the meaning of Rule 501 of Regulation D promulgated under the Securities Act
      of
      1933, as amended.

     

    45. Dated:_____________________  

     

    46.  (Signature
      of Transferee)

    
      
        
        

      

      
        13Exhibit
        10.25

       

      REGISTRATION
        RIGHTS AGREEMENT

       

      This
        Registration Rights Agreement (this “Agreement”)
        is
        made and entered into as of ______________________, 2007, by and between
        DRTATTOFF, LLC, a California limited liability company (the “Company”),
        and
        the purchaser that has executed the signature page of this Agreement (the
        “Purchaser”).

       

      Preliminary
        Statements

       

      The
        Purchaser has purchased Units, as defined in the Subscription Agreement of
        even
        date herewith, (the “Units”)
        of the
        Company, and one warrant to purchase one half Unit (the “Warrant”).
        The
        Units were purchased pursuant to that certain subscription agreement entered
        into between the Purchaser and the Company (the “Subscription
        Agreement”).
        The
        Company has agreed to grant the Purchaser certain registration rights in
        accordance with the terms of this Agreement. Therefore, in consideration
        of the
        mutual promises and covenants set forth herein, the parties agree as
        follows:

       

      1.  Definitions.
        Capitalized terms used and not otherwise defined herein that are defined
        in the
        Subscription Agreement shall have the meanings given such terms in the
        Subscription Agreement. As used in this Agreement, the following terms shall
        have the following meanings:

       

      “Commission”
means
        the Securities and Exchange Commission.

       

      “Exchange
        Act”
means
        the Securities Exchange Act of 1934, as amended, and any successor
        statute.

       

      “Filing
        Date”
        means,
        with respect to the Registration Statement required to be filed to cover
        the
        resale by the Holders of the Registrable Securities, the 45th
        calendar
        day following the Closing Date of the merger with Lifescience Opportunities,
        Inc.

       

      “Holder”
or
        “Holders”
means
        the Purchaser or Purchasers or any of their affiliates or transferees to
        the
        extent any of them hold Registrable Securities.

       

      “Indemnified
        Party”
shall
        have the meaning set forth in Section 5(b).

       

      “Indemnifying
        Party”
shall
        have the meaning set forth in Section 5(b).

       

      “Proceeding”
means
        an action, claim, suit, investigation or proceeding (including, without
        limitation, an investigation or partial proceeding, such as a deposition),
        whether commenced or threatened. 

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      “Prospectus”
means
        the prospectus included in the Registration Statement (including, without
        limitation, a prospectus that includes any information previously omitted
        from a
        prospectus filed as part of an effective registration statement in reliance
        upon
        Rule 430A promulgated under the Securities Act), as amended or supplemented
        by
        any prospectus supplement, with respect to the terms of the offering of any
        portion of the Registrable Securities covered by the Registration Statement,
        and
        all other amendments and supplements to the Prospectus, including post-effective
        amendments, and all material incorporated by reference or deemed to be
        incorporated by reference in such Prospectus. 

       

      “Registrable
        Securities”
means
        the Units purchased or purchased upon exercise of the Warrants, or other
        securities of the Company or any other issuer or issuable in respect of such
        Units (because of stock splits, stock dividends, reclassifications,
        recapitalizations, mergers, combinations or similar events, if applicable);
        provided, however, that the shares of Common Stock which are Registrable
        Securities shall cease to be Registrable Securities upon any sale or transfer
        of
        such shares pursuant to a Registration Statement, Section 4(1) of the Securities
        Act, Rule 144 under the Securities Act or otherwise. 

       

      “Registration
        Statement”
means
        a
        registration statement filed by the Company with the Commission on any
        registration form prescribed by the Commission permitting a secondary offering
        or distribution, other than on Form S-4, Form S-8 or similar forms.

       

      “Rule
        144”
means
        Rule 144 promulgated by the Commission pursuant to the Securities Act, as
        such
        Rule may be amended from time to time, or any similar rule or regulation
        hereafter adopted by the Commission having substantially the same effect
        as such
        Rule. 

       

      “Securities
        Act”
means
        the Securities Act of 1933, as amended, and any successor statute.

       

      “Trading
        Market”
means
        any of the Pink Sheets LLC electronic quotation service, NASD OTC Bulletin
        Board, NASDAQ Global Select Market, NASDAQ Global Market, NASDAQ Capital
        Market,
        American Stock Exchange or the New York Stock Exchange.

       

      “Units”
means
        the units of membership interests of the Company, and any securities into
        which
        such units shall hereinafter have been reclassified into.

       

      “Warrants”
means
        the Unit purchase warrants issued by the Company.

       

      2.  Registration.
        

       

      (a)  On
        or
        prior to the Filing Date, the Company shall prepare and file with the Commission
        a Registration Statement covering the resale of all Registrable Securities
        for
        an offering to be made on a continuous basis pursuant to Rule 415. The
        Registration Statement shall be on Form SB-2 (except if the Company is eligible
        to register for resale the Registrable Securities on Form S-3 in the future,
        the
        Company shall file a post effective amendment to the registration statement
        on
        Form S-3 covering the Registrable Securities and shall use its commercially
        reasonable efforts to cause such Registration Statement to be declared effective
        as promptly as practicable thereafter). 

       

      
        
          
          

        

        
          2

          
            

          

        

        
          
          

        

      

       

      (b)  The
        Company shall use its reasonable best efforts to cause the Registration
        Statement to be declared effective by the Commission as soon as practicable
        (including filing with the Commission a request for acceleration of
        effectiveness in accordance with Rule 461 promulgated under the Securities
        Act
        within five (5) Business Days after the date that the Company is notified
        (orally or in writing, whichever is earlier) by the Commission that a
        Registration Statement will not be “reviewed,” or not be subject to further
        review and the effectiveness of the Registration Statement may be accelerated)
        and shall use its commercially reasonable efforts to keep the Registration
        Statement continuously effective under the Securities Act until the earlier
        of:
        (i) the date that all Registrable Securities covered by the Registration
        Statement have been sold or may be sold by non-affiliates without volume
        restrictions pursuant to Rule 144(k) as determined by the counsel to the
        Company
        pursuant to a written opinion letter to such effect, addressed and acceptable
        to
        the Company's transfer agent and the affected Holders and (ii) the date which
        is
        the second anniversary of the date in which the Registration Statement was
        declared effective by the Commission (the “Effectiveness
        Period”).
        Such
        Registration Statement shall also cover, to the extent allowable under the
        Securities Act and the rules promulgated thereunder (including Rule 416),
        such
        indeterminate number of additional shares of Common Stock resulting from
        stock
        splits, stock dividends or similar transactions with respect to the Registrable
        Securities. It is agreed and understood that the Company shall, from time
        to
        time, be obligated to file an additional Registration Statement to cover
        any
        Registrable Securities which are not registered for resale pursuant to a
        pre-existing Registration Statement.

       

      (c)  If:
        (i)
        the Registration Statement is not filed on or prior to the Filing Date (if
        the
        Company files a Registration Statement without affording the Holders the
        opportunity to review and comment on the same as required by Section 3(a)
        hereof, the Company shall not be deemed to have satisfied this clause (i)),
        (ii)
        after its Effective Date such Registration Statement ceases for any reason
        to be
        effective and available to the Holders as to all Registrable Securities to
        which
        it is required to cover at any time prior to the expiration of its Effectiveness
        Period for more than 20 consecutive Trading Days or an aggregate of 50 Trading
        Days (which need not be consecutive)(any such failure or breach being referred
        to as an “Event,”
        and for
        purposes of clause (i) the date on which such Event occurs, or for purposes
        of
        clause (ii) the date which such 20 consecutive or 50 Trading Day period (as
        applicable) is exceeded, being referred to as “Event
        Date”),
        then
        in addition to any other rights available to the Holders: (x) on such Event
        Date
        the Company shall pay to each Holder an amount in cash, as partial liquidated
        damages and not as a penalty, equal to .5% of the aggregate Subscription
        Amount
        paid by such Holder pursuant to the Purchase Agreement (which remedy shall
        not
        be exclusive of any other remedies available under this Agreement); and (y)
        on
        each monthly anniversary of each such Event Date thereof (if the applicable
        Event shall not have been cured by such date) until the applicable Event
        is
        cured, the Company shall pay to each Holder an amount in cash, as partial
        liquidated damages and not as a penalty, equal to .5% of the aggregate
        Subscription Amount paid by such Holder pursuant to the Purchase Agreement.
        The
        parties agree that the Company will not be liable for liquidated damages
        under
        this Section 2(c) in respect of any consideration paid by the Purchasers
        upon
        exercise of the Warrants. If the Company fails to pay any partial liquidated
        damages pursuant to this Section in full within ten days after the date payable,
        the Company will pay interest thereon at a rate of 10% per annum (or such
        lesser
        maximum amount that is permitted to be paid by applicable law) to the Holder,
        accruing daily from the date such partial liquidated damages are due until
        such
        amounts, plus all such interest thereon, are paid in full. The partial
        liquidated damages pursuant to the terms hereof shall apply on a pro-rata
        basis
        for any portion of a month prior to the cure of an Event, except in the case
        of
        the first Event Date. Notwithstanding the foregoing, the maximum amount of
        payment to a Holder associated with any and all Events shall not exceed 10%
        of
        the aggregate Subscription Amount paid by such Holder pursuant to the Purchase
        Agreement.

       

      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

      

       

      (d) Each
        Holder shall furnish to the Company a completed Questionnaire in the form
        as
        provided by the Company (a “Selling
        Holder Questionnaire”).
        The
        Company shall not be required to include the Registrable Securities of a
        Holder
        in a Registration Statement and shall not be required to pay any liquidated
        or
        other damages under Section 2(c) to any Holder who fails to furnish to the
        Company a fully completed Selling Holder Questionnaire at least two Trading
        Days
        prior to the Filing Date (subject to the requirements set forth in Section
        3(a)).

       

      3.  Registration
        Procedures.
        When
        the Company proposes to effect the registration of any of the Registrable
        Securities under the Securities Act, the Company shall: 

       

      (a)  furnish
        to the Purchaser such number of copies of the Registration Statement and
        the
        Prospectus included therein (including each preliminary Prospectus) as the
        Purchaser reasonably may request to facilitate the public sale or disposition
        of
        the Registrable Securities covered by the Registration Statement;

       

      (b)  use
        its
        commercially reasonable efforts to register or qualify the Purchaser’s
        Registrable Securities covered by the Registration Statement under the
        securities or “blue sky” laws of such jurisdictions within the United States as
        the Purchaser may reasonably request, provided, however, that the Company
        shall
        not for any such purpose be required to qualify generally to transact business
        as a foreign corporation in any jurisdiction where it is not so qualified
        or to
        consent to general service of process in any such jurisdiction; and

       

      (c)  list
        the
        Registrable Securities covered by the Registration Statement with any Trading
        Market on which the Common Stock of the Company is then listed. 

       

      
        
          
          

        

        
          4

          
            

          

        

        
          
          

        

      

       

      4.  Registration
        Expenses.
        All
        expenses relating to the Company’s compliance with Sections 2 and 3 hereof,
        including, without limitation, all registration and filing fees, printing
        expenses, fees and disbursements of counsel and independent public accountants
        for the Company, fees and expenses (including reasonable counsel fees) incurred
        in connection with complying with state securities or “blue sky” laws, fees of
        the NASD, transfer taxes, fees of transfer agents and registrars are called
        “Registration Expenses”. All selling commissions applicable to the sale of
        Registrable Securities, including any fees and disbursements of any counsel
        to
        the Holders, are called “Selling Expenses” and shall be the responsibility of
        the Purchasers. The Company shall only be responsible for all Registration
        Expenses.

       

      5.  Indemnification.

       

      (a)  In
        the
        event of a registration of the Registrable Securities, the Holder (subject
        to
        the provisions of Section 5(b)) will indemnify and hold harmless the Company,
        and its officers, directors and each other person, if any, who controls the
        Company within the meaning of the Securities Act, against all losses, claims,
        damages or liabilities, joint or several, to which the Company or such persons
        may become subject under the Securities Act, the Exchange Act or otherwise,
        insofar as such losses, claims, damages or liabilities (or actions in respect
        thereof) arise out of or are based upon: (i) any untrue statement or
        alleged untrue statement of any material fact which was furnished in writing
        by
        the Holder to the Company expressly for use in (and such information is
        contained in) the Registration Statement under which such Registrable Securities
        were registered under the Securities Act pursuant to this Agreement, any
        preliminary Prospectus or final Prospectus contained therein, or any amendment
        or supplement thereof, or arise out of or are based upon the omission or
        alleged
        omission to state therein a material fact required to be stated therein or
        necessary to make the statements therein not misleading, and will reimburse
        the
        Company and each such person for any reasonable legal or other expenses incurred
        by them in connection with investigating or defending any such loss, claim,
        damage, liability or action, provided, however, that such Holder will be
        liable
        in any such case if and only to the extent that any such loss, claim, damage
        or
        liability arises out of or is based upon said Holder’s untrue statement or
        alleged untrue statement or omission or alleged omission so made in conformity
        with information furnished in writing to the Company by or on behalf of said
        Holder specifically for use in any such document, or (ii) in connection
        with a Holder’s sale of Registrable Securities, including without limitation
        alleged violations of Regulation M. Notwithstanding the provisions of this
        paragraph, no Holder shall be required to indemnify any person or entity
        in
        excess of the amount of the aggregate net proceeds received by said Holder
        in
        respect of Registrable Securities in connection with any such registration
        under
        the Securities Act.

       

      
        
          
          

        

        
          5

          
            

          

        

        
          
          

        

      

       

      (b)  Promptly
        after receipt by a party entitled to claim indemnification hereunder (an
        “Indemnified Party”) of notice of the commencement of any action, such
        Indemnified Party shall, if a claim for indemnification in respect thereof
        is to
        be made against a party hereto obligated to indemnify such Indemnified Party
        (an
“Indemnifying Party”), notify the Indemnifying Party in writing thereof, but the
        omission so to notify the Indemnifying Party shall not relieve it from any
        liability which it may have to such Indemnified Party other than under this
        Section 5(b) and shall only relieve it from any liability which it may have
        to
        such Indemnified Party under this Section 5(b) if and to the extent the
        Indemnifying Party is prejudiced by such omission. In case any such action
        shall
        be brought against any Indemnified Party and it shall notify the Indemnifying
        Party of the commencement thereof, the Indemnifying Party shall be entitled
        to
        participate in and, to the extent it shall wish, to assume and undertake
        the
        defense thereof with counsel reasonably satisfactory to such Indemnified
        Party,
        and, after notice from the Indemnifying Party to such Indemnified Party of
        its
        election so to assume and undertake the defense thereof, the Indemnifying
        Party
        shall not be liable to such Indemnified Party under this Section 5(b) for
        any
        legal expenses subsequently incurred by such Indemnified Party in connection
        with the defense thereof; if the Indemnified Party retains its own counsel,
        then
        the Indemnified Party shall pay all fees, costs and expenses of such counsel,
        provided, however, that, if the defendants in any such action include both
        the
        Indemnified Party and the Indemnifying Party and if counsel shall have
        reasonably concluded that there may be reasonable defenses available to the
        Indemnified Party which are different from or additional to those available
        to
        the Indemnifying Party or if the interests of the Indemnified Party reasonably
        may be deemed to conflict with the interests of the Indemnifying Party in
        either
        case which would prohibit such counsel from representing both parties under
        applicable conflicts of interest rules of professional ethics, the Indemnified
        Party shall have the right to select one separate counsel and to assume such
        legal defenses and otherwise to participate in the defense of such action,
        with
        the reasonable expenses and fees of such separate counsel and other expenses
        related to such participation to be reimbursed by the Indemnifying Party
        as
        incurred. Neither party shall settle any proceeding for which indemnification
        is
        sought without the written consent of the other party, which shall not be
        unreasonably withheld.

       

      (c)
         Notwithstanding
        any provision of this Agreement to the contrary, each Holder shall be treated
        individually and separately from all other Holders under this Section 5,
        and
        will not become the subject of any obligation under this Section 5 as a result
        of any action, failure to act, statement, omission, or otherwise of any other
        Holder hereunder.

       

      6.  Miscellaneous.

       

      (a)  Remedies.
        In the
        event of a breach by the Company or by a Holder, of any of their respective
        obligations under this Agreement, each Holder or the Company, as the case
        may
        be, in addition to being entitled to exercise all rights granted by law and
        under this Agreement, including recovery of damages, will be entitled to
        specific performance of its rights under this Agreement. 

       

      (b)  Compliance.
        The
        Purchaser covenants and agrees that it (i) will comply with the prospectus
        delivery requirements of the Securities Act as applicable to it in connection
        with sales of Registrable Securities pursuant to the Registration Statement
        and
        (ii) promptly furnish to the Company all information required to be disclosed
        in
        the Registration Statement and Prospectus concerning the Purchaser (including
        information in order to make the information previously furnished to the
        Company
        by such Purchaser not misleading) and any other information regarding such
        Purchaser and the distribution of such Registrable Securities as the Company
        may
        from time to time reasonably request.

       

      
        
          
          

        

        
          6

          
            

          

        

        
          
          

        

      

       

      (c)  Discontinued
        Disposition.
        The
        Holder agrees by its acquisition of such Registrable Securities that, upon
        receipt of a notice from the Company of the occurrence of a Discontinuation
        Event (as defined below), it will forthwith discontinue disposition of such
        Registrable Securities under the applicable Registration Statement until
        such
        Holder’s receipt of the copies of the supplemented Prospectus and/or amended
        Registration Statement or until it is advised in writing (the “Advice”) by the
        Company that the use of the applicable Prospectus may be resumed, and, in
        either
        case, has received copies of any additional or supplemental filings that
        are
        incorporated or deemed to be incorporated by reference in such Prospectus
        or
        Registration Statement. The Company may provide appropriate stop orders to
        enforce the provisions of this paragraph. For purposes of this Section 6(c),
        a
“Discontinuation Event” shall mean (i) when the Commission notifies the Company
        whether there will be a “review” of such Registration Statement and whenever the
        Commission comments in writing on such Registration Statement (the Company
        shall
        provide true and complete copies thereof and all written responses thereto
        to
        each of the Holders); (ii) any request by the Commission or any other Federal
        or
        state governmental authority for amendments or supplements to such Registration
        Statement or Prospectus or for additional information; (iii) the issuance
        by the
        Commission of any stop order suspending the effectiveness of such Registration
        Statement covering any or all of the Registrable Securities or the initiation
        of
        any Proceedings for that purpose; (iv) the receipt by the Company of any
        notification with respect to the suspension of the qualification or exemption
        from qualification of any of the Registrable Securities for sale in any
        jurisdiction, or the initiation or threatening of any Proceeding for such
        purpose; (v) the occurrence of any event or passage of time that makes the
        financial statements included in such Registration Statement ineligible for
        inclusion therein or any statement made in such Registration Statement or
        Prospectus or any document incorporated or deemed to be incorporated therein
        by
        reference untrue in any material respect or that requires any revisions to
        such
        Registration Statement, Prospectus or other documents so that, in the case
        of
        such Registration Statement or Prospectus, as the case may be, it will not
        contain any untrue statement of a material fact or omit to state any material
        fact required to be stated therein or necessary to make the statements therein,
        in light of the circumstances under which they were made, not misleading;
        and/or
        (vi) the occurrence or existence of any pending corporate development that,
        in the reasonable discretion of the Board of Directors of the Company, makes
        it
        appropriate to suspend the availability of the Registration Statement and
        the
        related Prospectus.

       

      (d)  Amendments
        and Waivers.
        The
        provisions of this Agreement, including the provisions of this sentence,
        may not
        be amended, modified or supplemented, and waivers or consents to departures
        from
        the provisions hereof may not be given, unless the same shall be in writing
        and
        signed by the Company and the Holders of a majority of the then outstanding
        Registrable Securities. Notwithstanding the foregoing, a waiver or consent
        to
        depart from the provisions hereof with respect to a matter that relates
        exclusively to the rights of certain Holders and that does not directly or
        indirectly affect the rights of other Holders may be given by Holders of
        at
        least a majority of the Registrable Securities to which such waiver or consent
        relates; provided, however, that the provisions of this sentence may not
        be
        amended, modified, or supplemented except in accordance with the provisions
        of
        the immediately preceding sentence.

       

      
        
          
          

        

        
          7

          
            

          

        

        
          
          

        

      

       

      7.  Notices.
        All
        notices and other communications required or permitted hereunder shall be
        in
        writing and shall be deemed to have been duly given one (1) business day
        after
        delivery to an overnight carrier with instructions to deliver to the applicable
        address set forth below, or, if sent by facsimile, upon receipt of a
        confirmation of delivery: 

       

      8.  Registered
        Holder:To
        his or
        her last known address as indicated on the Company’s books and
        records.

       

      9.  The
        Company:DRTATTOFF,
        LLC

      
         

        
          	 	
                  8500
                    Wilshire Blvd

                  Beverly
                    Hills CA 90211

                  Facsimile
                    No.: (310) 659-4159

                

        

      

      
      

      10.  Attention: James
        Morel, CEO

       

      
        	
                If
                  to any other Person who is

                then
                  the registered Holder:

              	To
                the address of such Holder as it appears in the 
	 	stock
                transfer books of the Company

      

          

      11.  Successors
        and Assigns.
        This
        Agreement shall inure to the benefit of and be binding upon the successors
        and
        permitted assigns of each of the parties and shall inure to the benefit of
        and
        be binding upon the Holders. Except as it relates to assignments to affiliates
        of the Company, the Company may not assign its rights or obligations hereunder
        without the prior written consent of each Holder. Each Holder may assign
        their
        respective rights hereunder in the manner and to the Persons as permitted
        under
        the Warrants and the Subscription Agreement with the prior written consent
        of
        the Company. No person shall have the rights of the Holder hereunder unless
        they
        have executed a joinder to the Agreement in a form reasonably acceptable
        to the
        Company.

       

      12.  Execution
        in Counterparts.
        This
        Agreement may be executed in any number of counterparts, each of which when
        so
        executed shall be deemed to be an original and, all of which taken together
        shall constitute one and the same Agreement. In the event that any signature
        is
        delivered by facsimile transmission, such signature shall create a valid
        binding
        obligation of the party executing (or on whose behalf such signature is
        executed) the same with the same force and effect as if such facsimile signature
        were the original thereof.

       

      
        
          
          

        

        
          8

          
            

          

        

        
          
          

        

      

       

      13.  Governing
        Law.
        All
        questions concerning the construction, validity, enforcement and interpretation
        of this Agreement shall be governed by and construed and enforced in accordance
        with the internal laws of the State of California, without regard to the
        principles of conflicts of law thereof. Each party agrees that all proceedings
        concerning the interpretations, enforcement and defense of the transactions
        contemplated by this Agreement (whether brought against a party hereto or
        its
        respective affiliates, directors, officers, shareholders, employees or agents)
        shall be commenced exclusively in the state and federal courts sitting in
        the
        State of California, County of Los Angeles. Each party hereto hereby irrevocably
        submits to the exclusive jurisdiction of the state and federal courts sitting
        in
        the State of California for the adjudication of any dispute hereunder or
        in
        connection herewith or with any transaction contemplated hereby or discussed
        herein, and hereby irrevocably waives, and agrees not to assert in any
        proceeding, any claim that it is not personally subject to the jurisdiction
        of
        any such court, that such proceeding is improper. Each party hereto hereby
        irrevocably waives personal service of process and consents to process being
        served in any such proceeding by mailing a copy thereof via registered or
        certified mail or overnight delivery (with evidence of delivery) to such
        party
        at the address in effect for notices to it under this Agreement and agrees
        that
        such service shall constitute good and sufficient service of process and
        notice
        thereof. Nothing contained herein shall be deemed to limit in any way any
        right
        to serve process in any manner permitted by law. The parties hereto hereby
        irrevocably waive, to the fullest extent permitted by applicable law, any
        and
        all right to trial by jury in any legal proceeding arising out of or relating
        to
        this Agreement or the transactions contemplated hereby. If any party shall
        commence a proceeding to enforce any provisions of this Agreement, then the
        prevailing party in such proceeding shall be reimbursed by the other party
        for
        its reasonable attorneys fees and other costs and expenses incurred with
        the
        investigation, preparation and prosecution of such proceeding.

       

      14.  Remedies.
        The
        remedies provided herein are cumulative and not exclusive of any remedies
        provided by law.

       

      15.  Severability.
        If any
        term, provision, covenant or restriction of this Agreement is held by a court
        of
        competent jurisdiction to be invalid, illegal, void or unenforceable, the
        remainder of the terms, provisions, covenants and restrictions set forth
        herein
        shall remain in full force and effect and shall in no way be affected, impaired
        or invalidated, and the parties hereto shall use their reasonable efforts
        to
        find and employ an alternative means to achieve the same or substantially
        the
        same result as that contemplated by such term, provision, covenant or
        restriction. It is hereby stipulated and declared to be the intention of
        the
        parties that they would have executed the remaining terms, provisions, covenants
        and restrictions without including any of such that may be hereafter declared
        invalid, illegal, void or unenforceable.

       

      16.  Headings.
        The
        headings in this Agreement are for convenience of reference only and shall
        not
        limit or otherwise affect the meaning hereof.

       

      [registration
        rights agreement signature page follows]

       

      
        
          
          

        

        
          9

          
            

          

        

        
          
          

        

      

       

      [registration
        rights agreement signature page]

       

      IN
        WITNESS WHEREOF, the parties have executed this Agreement as of the date
        first
        written above. 

       

      
        	
                DRTATTOFF,
                  LLC

              	 	
                PURCHASER:

              	 
	 	 	 	 
	
                By:

              	 	 	
                By:

              	 	 
	
                James
                  Morel, CEO 

              	 	
                Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}]]